Loading…
Rezolute, Inc.
Rezolute, Inc. (RZLT) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Redwood City, United States and has 58 employees. The company is worth $346.27M. The share price is 68.8% below its 52-week high of $11.46. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $5.24M. In that quarter, 1 of them opened or added to the position and 2 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -29.5% over 5Y.
today you would have $559.37▼ -44.1%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 14 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $3.58 | $2.36 | $4.90 | $0.99 | $2.07 | $4.78 | $11.99 | $5.75 | $4.50 | $44.25 | $50.00 | $73.00 | $62.50 | $159.00 | |
| P/B | 3.5x | 3.4x | 1.3x | 2.2x | 0.3x | 0.5x |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| CVCapsoVision, Inc | $6.53 | — | 24.8x | 0.00% | -335.06% | $347.46M |
| FENCFennec Pharmaceuticals Inc | $9.98 | — | 8.2x | 0.00% | -18.58% | $349.97M |
| INDPIndaptus Therapeutics, Inc. | $2.63 | — | 30.9x | 0.00% | -318.04% | $350.43M |
| KYTXKyverna Therapeutics, Inc. | $5.67 |
| 1.6x |
| 13.6x |
| 19.3x |
| — |
| 5.6x |
| 4.0x |
| 3.9x |
| 3.5x |
| — |
| EPS | -$0.75 | -$0.98 | -$1.33 | -$1.01 | -$2.32 | -$2.72 | -$3.54 | -$18.41 | -$27.00 | -$28.50 | -$42.00 | -$27.00 | -$52.00 | -$54.00 |
| ROE | -102.79% | -77.06% | -45.90% | -56.58% | -44.58% | -27.47% | -80.09% | -276.08% | -1737.79% | — | -237.77% | -170.25% | -125.50% | -151.88% | — |
Median of the years shown; P/E years above 200x are left out.
| — |
| 2.1x |
| 0.00% |
| -87.24% |
| $350.65M |
| RLMDRelmada Therapeutics Inc | $3.29 | — | 1.7x | 0.00% | -55.66% | $350.94M |
| ENTAEnanta Pharmaceuticals Inc | $11.62 | — | 3.3x | 0.00% | -70.12% | $338.44M |